C

Clorox

Manufactures and markets consumer cleaning products

Data Analytics Intern - Part-time days

Summer 2026Updated
$20/hr
Internship
Bachelor's
Olathe, KS, USA
In PersonFlexible part-time days; hours to be discussed and agreed.
Data & AnalyticsData Analysis

About the job

Requirements
  • Currently pursuing a degree in Data Analytics, Industrial Engineering, Statistics, Computer Science, or related field
  • Basic knowledge of SQL, Python, or R for data manipulation and analysis
  • Familiarity with data visualization tools (Power BI, Tableau, or similar)
  • Strong analytical and problem-solving skills with attention to detail
  • Ability to work collaboratively in a fast-paced manufacturing environment
Responsibilities
  • Collect, clean, and organize data from production systems, ERP, and quality control databases
  • Analyze manufacturing KPIs such as throughput, downtime, scrap rates, and cycle times
  • Develop dashboards and reports using tools like Excel, Power BI, or Tableau to monitor plant performance
  • Assist in root cause analysis for production issues using statistical methods
  • Support predictive analytics projects (e.g., machine maintenance, demand forecasting)
  • Document findings and present insights to operations and leadership teams
Desired Qualifications
  • Understanding of Lean Manufacturing and Six Sigma principles
  • Experience with ERP systems (SAP, Oracle, or similar)
  • Knowledge of manufacturing processes and operational KPIs

About the company

Clorox makes and sells cleaning supplies, household products, and some food products through a portfolio of well-known brands. Its products are offered to both consumers and professional users and distributed via mass merchandisers, grocery stores, and online channels around the world. How the products work: cleaning and disinfecting products are used to sanitize and maintain surfaces and homes, while household items and food-related products support everyday routines. How it stands out: instead of relying on a single product or category, Clorox combines a broad brand lineup with sales across multiple markets and customer channels, giving it broad reach and stability. Its goal is to provide trusted brands that help people keep spaces clean and safe while meeting the needs of both individual consumers and professional customers.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Oakland, CA

Founded

1913

Get referred to Clorox

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 sales reached $1.95 billion, with GOJO adding roughly ten points.
  • Fiscal 2027 guidance calls for 13% to 14% sales growth and $5.41 EPS.
  • Clorox Purell and Clorox Professional are strong, reinforcing health and hygiene scale.

What critics are saying

  • September 3, 2026 Mistolin and Lestoil recall hit 6.3 million bottles and lawsuits.
  • Linda Rendle's CEO search creates leadership uncertainty during GOJO integration.
  • Fiscal 2026 organic sales fell 8%, and gross margin dropped 290 basis points.

What makes Clorox unique

  • Clorox Purell became over half of sales after the April 2026 GOJO acquisition.
  • Pine-Sol tests TikTok Shop scents, using consumer co-creation to accelerate product iteration.
  • Chris Hyder and Nina Barton simplify execution under a 2026 operating structure reset.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Unlimited Paid Time Off
  • Family Planning Benefits
  • Fertility Treatment Support
  • Wellness Program
  • Mental Health Support

Growth & Insights and Company News

6 month growth

2%

1 year growth

2%

2 year growth

2%
PR Newswire
Oct 29th, 2026
Clorox appoints Fabian Garcia as CEO.

Clorox appoints Fabian Garcia as CEO. Oct 29, 2026, 07:00 ET Matthew Shattock to Resume Position as Independent Chair OAKLAND, Calif., Oct. 29, 2026 /PRNewswire/ - The Clorox Company (NYSE: CLX) today announced that its Board of Directors has appointed Fabian Garcia as CEO, effective Jan. 5, 2027, following a comprehensive search. Garcia will succeed Linda Rendle, who announced in May that she would step down for health reasons. Rendle will continue to serve as chair and CEO until Garcia assumes the CEO role. At the time of Garcia's appointment, he will join the Board of Directors, and Matthew Shattock, the company's lead independent director and former Board chair, will become independent chair. On that date, Rendle will step down as CEO and as a director, while continuing to serve in an advisory capacity through April 2, 2027 to ensure a smooth transition. "Fabian is an accomplished global business leader with an exceptional track record of delivering results, building enduring brands and developing high-performing teams," said Shattock. "His experience leading large-scale consumer businesses, advancing innovation, successfully managing complex and evolving customer and channel dynamics, and driving disciplined growth makes him well suited to lead Clorox. The Board is confident that Fabian has the vision and leadership to build on the strong foundation Linda has established, strengthen execution and position Clorox for sustainable value creation." Shattock continued, "We are also incredibly grateful for Linda's leadership through some of the most consequential moments in the company's history. She strengthened the business and positioned it for the future. We greatly appreciate her continued support during this transition." Garcia currently serves as president of Unilever Personal Care and is a member of the Unilever Leadership Executive team, bringing more than four decades of global consumer products leadership experience. Since joining Unilever in 2020, he has held several senior leadership roles, including serving as president of Unilever North America. Before joining Unilever, Garcia served as CEO of Revlon and as chief operating officer for Global Innovation and Growth at Colgate-Palmolive, where he led global growth strategy, consumer innovation and operational productivity initiatives. Earlier in his career, he held a series of global leadership roles at Procter & Gamble, helping shape his foundation in brand building, commercial excellence and consumer-focused growth. Garcia currently serves on the Board of Directors of Wells Fargo, having previously served on the boards of Kimberly-Clark and Arrow Electronics. "I am honored to join Clorox and grateful for the Board's confidence," said Garcia. "This is a company with an exceptional portfolio of trusted brands, deep consumer loyalty, a clear purpose and a talented team. While there is more work ahead to strengthen performance and realize the company's full potential, I am energized by the opportunity and confident in Clorox's future. I look forward to working with the team to build on these strengths, drive growth and create long-term value for all of our stakeholders." "It has been the privilege of my career to lead Clorox and work alongside such talented teammates around the world," said Rendle. "As I prepare to hand over leadership of this remarkable company in the coming months, I do so with great confidence. Clorox's future is bright, and I look forward to seeing all that the company will accomplish under Fabian's leadership." Clorox will report its first-quarter fiscal year 2027 earnings results on Monday, Nov. 2, and Rendle and Chief Financial Officer Luc Bellet will participate in an earnings call with analysts. Links to the webcast, press release and prepared remarks can be found at Clorox Quarterly Results. About The Clorox Company The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands, including Brita(R), Burt's Bees(R), Clorox(R), Fresh Step(R), Glad(R), Hidden Valley(R), Kingsford(R), Liquid-Plumr(R), Pine-Sol(R) and Purell(R) as well as international brands such as Chux(R), Clorinda(R) and Poett(R). Visit thecloroxcompany.com to learn more. SOURCE The Clorox Company

ClassAction.org
Sep 29th, 2026
Clorox recall: class action lawsuit filed over alleged Mistolin, Lestoil contamination.

Clorox recall: class action lawsuit filed over alleged Mistolin, Lestoil contamination. A proposed class action lawsuit alleges that The Clorox Company failed to warn consumers that millions of bottles of scented Mistolin and Lestoil multi-purpose cleaners sold in Puerto Rico and the U.S. Virgin Islands were potentially contaminated with a dangerous bacterium that could cause serious infections. The 39-page lawsuit against The Clorox Company was filed in the wake of the United States Consumer Product Safety Commission's (CPSC) announcement on September 3, 2026 of the recall of approximately 6.3 million bottles of scented Mistolin and Lestoil due to the cleaners' potential contamination with Pseudomonas aeruginosa, a bacterial pathogen commonly found in soil or water that can infect the blood, lungs, urinary tract, eyes and open wounds. According to the case, Clorox knew or should have known of the contamination risk - particularly after the 2022 recall of 37 million bottles of Pine-Sol cleaners and a hefty civil penalty for its delayed reporting of the problem - yet continued to market, distribute and sell the Mistolin and Lestoil cleaners as safe and fit for their ordinary purpose without warning consumers that the products potentially contained a harmful pathogen. The filing contends that the recalled Clorox cleaners, which the case says are "ubiquitous" in Puerto Rico, have "no lawful market value, cannot safely be used as directed, and must be discarded." Compounding matters, the lawsuit claims, is that Clorox failed to provide direct notice of the recall to consumers in Puerto Rico and the U.S. Virgin Islands - where the cleaners are found in many households - or through a sustained Spanish-language outreach campaign to reach the hundreds of thousands of consumers who purchased the products. The suit goes on to allege that the Clorox recall is inadequate given that the relief offered by the company "fall[s] far short of making consumers whole," not to mention fails to reimburse those who incurred additional costs to remediate and clean areas where the adulterated products were used. "Even after the reported hazards became known, Defendant continued to prioritize profits over safety," the lawsuit alleges. "Despite finally acknowledging the Defect, Defendant has still failed to provide consumers... with any meaningful remedy." Clorox was on notice of potential cleaning products contamination, lawsuit argues. According to the Clorox lawsuit, the company is "well aware" of the risks associated with Pseudomonas aeruginosa, as it is the same bacterium that led the conglomerate to recall roughly 37 million bottles of Pine-Sol in October 2022. In January of this year, "the very period in which the [Mistolin and Lestoil cleaners] were being manufactured," the case points out, Clorox agreed to pay a $14.15 million civil penalty to resolve CPSC charges that the company knowingly failed to immediately report the Pine-Sol contamination to the federal government, despite Clorox's own microbiologists having documented possible contamination in its storage tanks as early as 2019. The complaint says that Clorox subsequently agreed to improve its control and compliance procedures and to submit annual compliance reports to the CPSC. Additionally, Clorox eventually agreed to pay $5.65 million in a class action settlement to resolve several related lawsuits, including Charles v. The Clorox Company, that alleged the company sold the affected Pine-Sol products with no disclosure of potential contamination, the suit mentions. In light of the foregoing, the suit charges that Clorox knew "from direct and expensive experience," that its Mistolin and Lestoil scented multi-surface cleaners, which the case says are relatively similar to the recalled Pine-Sol products, were vulnerable to contamination, yet "did nothing" with regard to warning consumers. In both cases only the scented variants were contaminated, while the unscented formulation was not, demonstrating that the fragrance and preservative systems Defendant selected for its scented cleaners are inadequate to prevent Pseudomonas growth, and that Defendant failed to correct that inadequacy across its scented cleaner portfolio after the Pine-Sol recall." The case goes on to state that Clorox knew or should have known of the contamination in the products at issue through its own microbial testing, pre-market safety testing, product design and engineering, and more, yet failed to disclose that the products were adulterated until the September 2026 recall, meaning the contaminated products were on shelves for months after they had been produced. Mistolin and Lestoil recall is inadequate, case claims. The class action lawsuit contends that the Mistolin and Lestoil recall falls well short of making consumers whole. For one, although consumers were told to immediately stop using the cleaners at issue and dispose of them in the trash, receiving a refund through the recall requires completing an online form and supplying a photo of the bottle's UPC code, the case relays. In light of this, the suit says that the program "excludes most of the Products that were sold" in that the cleaners at issue were sold for 17 months before the recall, and the "great majority" of the 6.3 million units sold "have already been used up and discarded." "Yet Defendant conditions any refund on a photograph of the UPC code on the bottle," the filing reiterates. "A consumer who no longer has the bottle receives nothing, no matter how many bottles they bought and used." Second, the amount of any refund a consumer may receive through the recall is set by Clorox, and not dependent on what they paid - approximately $1.40 to $8.00 per bottle, per the suit - for the affected products, the lawsuit continues. The case also says that the recall program fails to compensate consumers for remediation and cleaning expenses they may have incurred from spraying and pouring an adulterated product throughout their house, including on floors, countertops, sinks, tubs, and more. "Reasonable consumers who learn that they have done so must now disinfect those surfaces with a product they can trust, discard and replace the mops, sponges, and cloths that were saturated with the contaminated Products, and purchase replacement cleaning products to do so," the filing elaborates. Additionally, the lawsuit claims that the recall unfairly shifts to consumers the burden and risk associated with disposing of contaminated cleaning products, as users generally lack the guidance or protective measures needed to handle infectious pathogens. Which Clorox products were recalled? The filing says the products at issue in the recall are all Mistolin and Lestoil scented liquid multi-purpose cleaners in 28-, 40-, 64- and 128-ounce bottles manufactured between April 1, 2025 and June 17, 2026 and sold throughout Puerto Rico and the U.S. Virgin Islands. Who is covered by the Clorox lawsuit? The Clorox class action lawsuit looks to cover all individuals who purchased one or more of the recalled Mistolin and Lestoil products in Puerto Rico or the U.S. Virgin Islands for personal or household use and not for resale during the fullest period allowed by law. Generally, you don't need to do anything to join or sign up for a class action lawsuit when it is initially filed. Should the case be resolved with a class action settlement, settlement class members will typically receive written notice of the deal via mail and/or email with instructions on any next steps and details about their legal rights. If you've purchased one or more scented Mistolin or Lestoil cleaning products, or just want to stay informed about class action lawsuit and class action settlement news, sign up for ClassAction.org's free weekly newsletter. Check out ClassAction.org's lawsuit list for the latest open class action lawsuits and investigations. Case Spotlight Video game addiction lawsuits. If your child suffers from video game addiction - including Fortnite addiction or Roblox addiction - you may be able to take legal action. Gamers 18 to 22 may also qualify. Kratom 7-OH lawsuits. Anyone who has used 7-OH kratom products and suffered a serious injury, such as overdose, heart attack or addiction, may be able to take legal action. How do I join a class action lawsuit? Stay Current New cases and investigations, settlement deadlines, and news straight to your inbox. Last Updated on September 29, 2026 - 2:44 PM

Ticker Report
Aug 21st, 2026
OVERSEA CHINESE BANKING Corp Ltd Makes New $7.06 Million Investment in The Clorox Company $CLX

OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 73,976 shares of the company’s stock, valued at approximately $7,060,000. OVERSEA CHINESE BANKING Corp […]

Yahoo Finance
Aug 12th, 2026
Clorox beats revenue estimates despite 2% decline, misses guidance with $5.85 EPS outlook

Clorox's second quarter revenue beat analyst expectations at $1.95 billion, despite a 2% year-on-year decline. CEO Linda Rendle attributed performance to improvements in product quality, brand investments, and promotional execution. The company reported adjusted EPS of $1.66, narrowly beating estimates. However, operating margin fell to 12.9% from 21% in the prior year period. Clorox guided adjusted EPS of $5.85 for financial year 2027, missing analyst expectations by 1.7%. Management highlighted ongoing productivity initiatives and early integration of the GOJO acquisition. During the earnings call, analysts questioned market share expectations, promotional activity levels, and dividend policy. The company expects sequential share improvement, particularly in Home Care and Professional segments, while acknowledging challenges in Litter and Grilling categories.

PR Newswire
Aug 3rd, 2026
Clorox Q4 sales drop 2% to $1.95B, forecasts up to 14% FY27 growth after GOJO acquisition

Clorox reported fourth-quarter fiscal 2026 results ending 30 June, with net sales decreasing 2% to $1.95 billion. The company completed its acquisition of GOJO Industries in April 2026, which added approximately 10 percentage points to sales. Organic sales fell 13%, primarily due to lapping incremental shipments related to an ERP transition. Diluted earnings per share dropped 50% to $1.34 from $2.68 year-over-year. Gross margin decreased 520 basis points to 41.3%. For fiscal 2027, Clorox expects net sales growth of 13% to 14%, including 9.5 points from the GOJO acquisition. Organic sales are projected to increase 3.5% to 4.5%. Adjusted EPS is forecast between $5.70 and $6.00, representing growth of 3% to 8%. The company completed its five-year US ERP implementation during the fiscal year.

INACTIVE